Computational Saturation Screen Reveals the Landscape of Mutations in Human Fumarate Hydratase
暂无分享,去创建一个
[1] Leland McInnes,et al. UMAP: Uniform Manifold Approximation and Projection , 2018, J. Open Source Softw..
[2] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[3] François Stricher,et al. The FoldX web server: an online force field , 2005, Nucleic Acids Res..
[4] Burkhard Rost,et al. Correlating protein function and stability through the analysis of single amino acid substitutions , 2009, BMC Bioinformatics.
[5] K. Lindorff-Larsen,et al. Computational and cellular studies reveal structural destabilization and degradation of MLH1 variants in Lynch syndrome , 2019, eLife.
[6] D. Baker,et al. Role of conformational sampling in computing mutation‐induced changes in protein structure and stability , 2011, Proteins.
[7] R. Huber,et al. Crystallographic refinement and atomic models of two different forms of citrate synthase at 2.7 and 1.7 A resolution. , 1984, Journal of molecular biology.
[8] Jean-Pierre Bayley,et al. The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency , 2008, BMC Medical Genetics.
[9] J. Shendure,et al. The origins, determinants, and consequences of human mutations , 2015, Science.
[10] A. Rowan,et al. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. , 2005, The Journal of molecular diagnostics : JMD.
[11] Eran Segal,et al. A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation. , 2018, Molecular cell.
[12] M. Simpson,et al. Germline FH mutations presenting with pheochromocytoma. , 2014, The Journal of clinical endocrinology and metabolism.
[13] S. Dhanasekaran,et al. Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): A Contemporary Review and Practical Discussion of the Differential Diagnosis for HLRCC-Associated Renal Cell Carcinoma. , 2018, Archives of pathology & laboratory medicine.
[14] A. Clarke,et al. Structural basis of substrate specificity in malate dehydrogenases: crystal structure of a ternary complex of porcine cytoplasmic malate dehydrogenase, alpha-ketomalonate and tetrahydoNAD. , 1999, Journal of molecular biology.
[15] The role of the allosteric B site in the fumarase reaction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[16] Bartek Wilczynski,et al. Biopython: freely available Python tools for computational molecular biology and bioinformatics , 2009, Bioinform..
[17] E. Shaulian,et al. Fumarase: A Mitochondrial Metabolic Enzyme and a Cytosolic/Nuclear Component of the DNA Damage Response , 2010, PLoS biology.
[18] Berk Hess,et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers , 2015 .
[19] Joshua M. Korn,et al. Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.
[20] Xian-Ming Pan,et al. New method for accurate prediction of solvent accessibility from protein sequence , 2001, Proteins.
[21] Luis Serrano,et al. FoldX 5.0: working with RNA, small molecules and a new graphical interface , 2019, Bioinform..
[22] Huan‐Xiang Zhou,et al. Prediction of solvent accessibility and sites of deleterious mutations from protein sequence , 2005, Nucleic acids research.
[23] I. Bahar,et al. Gaussian Dynamics of Folded Proteins , 1997 .
[24] Jens Rudat,et al. FoldX as Protein Engineering Tool: Better Than Random Based Approaches? , 2018, Computational and structural biotechnology journal.
[25] Frank DiMaio,et al. Prediction of Protein Mutational Free Energy: Benchmark and Sampling Improvements Increase Classification Accuracy , 2020, Frontiers in Bioengineering and Biotechnology.
[26] C. Frezza,et al. Fumarate hydratase in cancer: A multifaceted tumour suppressor. , 2020, Seminars in cell & developmental biology.
[27] Ivet Bahar,et al. ProDy: Protein Dynamics Inferred from Theory and Experiments , 2011, Bioinform..
[28] Jingjing Ye,et al. Statistical method on nonrandom clustering with application to somatic mutations in cancer , 2010, BMC Bioinformatics.
[29] Philip M. Kim,et al. Predicting changes in protein stability caused by mutation using sequence‐and structure‐based methods in a CAGI5 blind challenge , 2019, Human mutation.
[30] K. Kavanagh,et al. Structural basis of fumarate hydratase deficiency , 2011, Journal of Inherited Metabolic Disease.
[31] O. Pines,et al. Fumarase is involved in DNA double-strand break resection through a functional interaction with Sae2 , 2018, Current Genetics.
[32] M. Nonato,et al. Structural, biochemical and biophysical characterization of recombinant human fumarate hydratase , 2019, The FEBS journal.
[33] Tomoyoshi Soga,et al. The emerging role of fumarate as an oncometabolite , 2012, Front. Oncol..
[34] C. Stout,et al. Crystal structures of aconitase with isocitrate and nitroisocitrate bound. , 1993, Biochemistry.
[35] Oliver Beckstein,et al. MDAnalysis: A toolkit for the analysis of molecular dynamics simulations , 2011, J. Comput. Chem..
[36] Andreas P. Eichenberger,et al. Definition and testing of the GROMOS force-field versions 54A7 and 54B7 , 2011, European Biophysics Journal.
[37] G. G. Galli,et al. The landscape of cancer cell line metabolism , 2019, Nature Medicine.
[38] I. Leigh,et al. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer , 2005, The British journal of dermatology.
[39] Roland L. Dunbrack,et al. The Rosetta all-atom energy function for macromolecular modeling and design , 2017, bioRxiv.
[40] S. Bouvier,et al. Systematic mutation of bacteriophage T4 lysozyme. , 1991, Journal of molecular biology.
[41] W. Anderson,et al. Crystal structure of T4-lysozyme generated from synthetic coding DNA expressed in Escherichia coli. , 1988, Protein engineering.
[42] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.